SEPSF
ASEP Medical Holdings Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.06 |
| Day High | $0.06 |
| Day Low | $0.06 |
| Volume | 10,000 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 11.12M |
| Total Debt | $519K |
| Cash Equivalents | $513K |
| Revenue | $212K |
| Net Income | $-5.59M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $121K |
| EPS (TTM) | $-0.71 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.44M |
| Sales | $212K |
| Income | $-5.59M |
| Book/sh | $0.33 |
| Cash/sh | $0.06 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 0.32 |
| Current Ratio | 0.32 |
| Debt/Eq | 7.74 |
Returns & Margins
| ROA | -8.22% |
| ROE | -88.01% |
| Gross Margin | 100.00% |
| Operating Margin | -703.41% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/S | 0.41 |
| P/B | 0.03 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.12 |
| RSI | nan |
| Shares Float | 5.35M |
| Volatility | -1.84 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | +0.00% |
| YTD | +0.00% |
| Year | -97.18% |
| 3 Years | -99.65% |
| 10 Years | -99.61% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $0.01 | 0 |
| 2026-06-12 | $0.01 | 0 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 0 |
| 2026-06-08 | $0.01 | 0 |
| 2026-06-05 | $0.01 | 0 |
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 0 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 0 |
| 2026-05-18 | $0.01 | 0 |
About ASEP Medical Holdings Inc.
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on SEPSF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $134,880 | $155,401 | $7,117 |
| Cost Of Revenue | $134,880 | $155,401 | $7,117 |
| Total Revenue | $21,140 | $0 | $0 |
| Operating Revenue | $21,140 | $0 | $0 |
| Expenses | |||
| Interest Expense | $270 | $814 | $101,999 |
| Total Expenses | $7,742,403 | $5,442,652 | $1,977,625 |
| Other Income Expense | $-1,708,980 | $-402,920 | $-263,939 |
| Net Non Operating Interest Income Expense | $-270 | $-814 | $-101,999 |
| Interest Expense Non Operating | $270 | $814 | $101,999 |
| Operating Expense | $7,607,523 | $5,287,251 | $1,970,508 |
| Other Operating Expenses | $1,402,972 | $963,038 | $47,250 |
| General And Administrative Expense | $4,231,742 | $2,426,779 | $1,672,482 |
| Other Non Operating Income Expenses | - | $-814 | $-25,610 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-8,227,328 | $-4,524,981 | $-2,200,086 |
| Net Interest Income | $-270 | $-814 | $-101,999 |
| Normalized Income | $-6,518,348 | $-4,128,202 | $-1,936,147 |
| Net Income From Continuing And Discontinued Operation | $-8,227,328 | $-4,524,981 | $-2,200,086 |
| Total Operating Income As Reported | $-7,721,263 | $-5,442,652 | $-2,054,014 |
| Net Income Common Stockholders | $-8,227,328 | $-4,524,981 | $-2,200,086 |
| Net Income | $-8,227,328 | $-4,524,981 | $-2,200,086 |
| Net Income Including Noncontrolling Interests | $-9,430,513 | $-5,757,286 | $-2,343,563 |
| Net Income Continuous Operations | $-9,430,513 | $-5,757,286 | $-2,343,563 |
| Pretax Income | $-9,430,513 | $-5,846,386 | $-2,343,563 |
| Special Income Charges | $-1,704,864 | $-400,521 | $0 |
| Operating Income | $-7,721,263 | $-5,442,652 | $-1,977,625 |
| Depreciation Amortization Depletion Income Statement | $1,294,266 | $1,282,394 | $177,177 |
| Depreciation And Amortization In Income Statement | $1,294,266 | $1,282,394 | $177,177 |
| Amortization Of Intangibles Income Statement | $1,294,266 | $1,282,394 | $177,177 |
| Gross Profit | $-113,740 | $-155,401 | $-7,117 |
| Per Share | |||
| Diluted EPS | $-1.32 | $-0.80 | $-0.39 |
| Basic EPS | $-1.32 | $-0.80 | $-0.39 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $-6,141 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,426,997 | $-4,160,258 | $-1,800,448 |
| Total Unusual Items | $-1,708,980 | $-402,920 | $-263,939 |
| Total Unusual Items Excluding Goodwill | $-1,708,980 | $-402,920 | $-263,939 |
| Reconciled Depreciation | $1,294,266 | $1,282,394 | $177,177 |
| EBITDA (Bullshit earnings) | $-8,135,977 | $-4,563,178 | $-2,064,387 |
| EBIT | $-9,430,243 | $-5,845,572 | $-2,241,564 |
| Diluted Average Shares | $6,223,537 | $5,619,609 | $5,613,034 |
| Basic Average Shares | $6,223,537 | $5,619,609 | $5,613,034 |
| Diluted NI Availto Com Stockholders | $-8,227,328 | $-4,524,981 | $-2,200,086 |
| Minority Interests | $1,203,185 | $1,232,305 | $143,477 |
| Tax Provision | $0 | $-89,100 | $0 |
| Other Special Charges | $429,864 | - | - |
| Restructuring And Mergern Acquisition | $1,275,000 | $400,521 | $0 |
| Gain On Sale Of Security | $-4,116 | $-2,399 | $-263,939 |
| Amortization | $1,294,266 | $1,282,394 | $177,177 |
| Research And Development | $678,543 | $615,040 | $73,599 |
| Selling General And Administration | $4,231,742 | $2,426,779 | $1,672,482 |
| Other Gand A | $1,497,387 | $671,270 | $634,294 |
| Salaries And Wages | $2,734,355 | $1,755,509 | $1,038,188 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-10,337,570 | $-8,159,741 | $-6,638,666 |
| Total Assets | $25,612,686 | $27,078,589 | $30,716,132 |
| Total Non Current Assets | $25,361,743 | $23,679,944 | $24,961,903 |
| Goodwill And Other Intangible Assets | $22,949,560 | $23,629,740 | $24,897,860 |
| Other Intangible Assets | $22,949,560 | $23,629,740 | - |
| Current Assets | $250,943 | $3,398,645 | $5,754,229 |
| Prepaid Assets | $160,799 | $1,153,636 | $390,761 |
| Receivables | $25,423 | $114,619 | $73,398 |
| Taxes Receivable | $25,423 | $114,619 | $73,398 |
| Cash Cash Equivalents And Short Term Investments | $64,721 | $2,130,390 | $5,290,070 |
| Cash And Cash Equivalents | $64,721 | $2,130,390 | $5,290,070 |
| Cash Financial | $64,721 | $2,130,390 | $5,290,070 |
| Debt | |||
| Total Debt | $20,270 | - | - |
| Current Debt And Capital Lease Obligation | $20,270 | - | - |
| Current Debt | $20,270 | - | - |
| Other Current Borrowings | $20,270 | - | - |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $3,051,861 | $528,161 | $144,204 |
| Total Non Current Liabilities Net Minority Interest | $2,056,274 | $0 | $0 |
| Non Current Deferred Liabilities | $2,056,274 | $0 | - |
| Current Liabilities | $995,587 | $528,161 | $144,204 |
| Current Deferred Liabilities | $297,586 | $0 | - |
| Payables And Accrued Expenses | $677,731 | $528,161 | $144,204 |
| Payables | $677,731 | $528,161 | $144,204 |
| Accounts Payable | $677,731 | $528,161 | $144,204 |
| Interest Payable | - | - | $19,288 |
| Equity | |||
| Common Stock Equity | $12,611,990 | $15,469,999 | $18,259,194 |
| Total Equity Gross Minority Interest | $22,560,825 | $26,550,428 | $30,571,928 |
| Stockholders Equity | $12,611,990 | $15,469,999 | $18,259,194 |
| Other Equity Interest | $744,699 | $241,714 | $35,921 |
| Retained Earnings | $-14,983,767 | $-6,725,067 | $-2,200,086 |
| Long Term Equity Investment | $2,375,000 | $0 | - |
| Other | |||
| Ordinary Shares Number | $7,418,408 | $6,213,034 | $5,613,034 |
| Share Issued | $7,418,408 | $6,213,034 | $5,613,034 |
| Tangible Book Value | $-10,337,570 | $-8,159,741 | $-6,638,666 |
| Invested Capital | $12,632,260 | $15,469,999 | $18,259,194 |
| Working Capital | $-744,644 | $2,870,484 | $5,610,025 |
| Total Capitalization | $12,611,990 | $15,469,999 | $18,259,194 |
| Minority Interest | $9,948,835 | $11,080,429 | $12,312,734 |
| Additional Paid In Capital | $2,805,442 | $2,111,220 | $956,227 |
| Capital Stock | $24,045,616 | $19,842,132 | $19,467,132 |
| Common Stock | $24,045,616 | $19,842,132 | $19,467,132 |
| Non Current Deferred Revenue | $2,056,274 | $0 | - |
| Current Deferred Revenue | $297,586 | $0 | - |
| Investments And Advances | $2,375,000 | $0 | - |
| Investmentsin Joint Venturesat Cost | $2,375,000 | $0 | - |
| Net PPE | $37,183 | $50,204 | $64,043 |
| Accumulated Depreciation | $-29,458 | $-15,210 | $-1,371 |
| Gross PPE | $66,641 | $65,414 | $65,414 |
| Other Properties | $66,641 | $65,414 | $65,414 |
| Current Accrued Expenses | - | - | $19,288 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | - | $-2,717,069 | $-3,614,911 | $-1,306,786 |
| Operating Activities | ||||
| Operating Gains Losses | $183,339 | $429,864 | - | $262,701 |
| Operating Cash Flow | - | $-2,712,598 | $-3,614,476 | $-1,191,064 |
| Cash Flow From Continuing Operating Activities | - | $-2,712,598 | $-3,614,476 | $-1,191,064 |
| Investing Activities | ||||
| Capital Expenditure | - | $-4,471 | $-435 | $-115,722 |
| Investing Cash Flow | - | $-4,471 | $124,796 | $146,082 |
| Cash Flow From Continuing Investing Activities | - | $-4,471 | $124,796 | $146,082 |
| Capital Expenditure Reported | - | - | $0 | $-50,308 |
| Financing Activities | ||||
| Issuance Of Capital Stock | - | $587,000 | $0 | $140,500 |
| Financing Cash Flow | - | $651,400 | $330,000 | $6,335,052 |
| Cash Flow From Continuing Financing Activities | - | $651,400 | $330,000 | $6,335,052 |
| Net Other Financing Charges | - | $-15,600 | - | $-171,198 |
| Net Common Stock Issuance | - | $587,000 | $0 | $140,500 |
| Common Stock Issuance | - | $587,000 | $0 | $140,500 |
| Other | ||||
| Other Non Cash Items | $-387,103 | $1,389,130 | $250,583 | $76,389 |
| Issuance Of Debt | - | $20,000 | $330,000 | $500,000 |
| End Cash Position | - | $64,721 | $2,130,390 | $5,290,070 |
| Beginning Cash Position | - | $2,130,390 | $5,290,070 | $0 |
| Changes In Cash | - | $-2,065,669 | $-3,159,680 | $5,290,070 |
| Proceeds From Stock Option Exercised | - | $60,000 | $0 | $5,865,750 |
| Net Issuance Payments Of Debt | - | $20,000 | $330,000 | $500,000 |
| Net Long Term Debt Issuance | - | $20,000 | $330,000 | $500,000 |
| Long Term Debt Issuance | - | $20,000 | $330,000 | $500,000 |
| Net Business Purchase And Sale | - | $0 | $125,231 | $261,804 |
| Sale Of Business | - | $0 | $125,231 | $261,804 |
| Net Intangibles Purchase And Sale | - | $-3,244 | $-435 | $0 |
| Purchase Of Intangibles | - | $-3,244 | $-435 | $0 |
| Net PPE Purchase And Sale | - | $-1,227 | $0 | $-65,414 |
| Purchase Of PPE | - | $-1,227 | $0 | $-65,414 |
| Change In Working Capital | - | $1,652,601 | $-420,139 | $-319,995 |
| Change In Payables And Accrued Expense | - | $570,567 | $383,956 | $144,164 |
| Change In Prepaid Assets | - | $992,838 | $-762,875 | $-390,761 |
| Change In Receivables | - | $89,196 | $-41,220 | $-73,398 |
| Stock Based Compensation | - | $1,952,054 | $1,119,072 | $956,227 |
| Deferred Tax | - | $0 | $-89,100 | $0 |
| Deferred Income Tax | - | $0 | $-89,100 | $0 |
| Depreciation Amortization Depletion | - | $1,294,266 | $1,282,394 | $177,177 |
| Depreciation And Amortization | - | $1,294,266 | $1,282,394 | $177,177 |
| Amortization Cash Flow | - | $1,294,266 | $1,282,394 | $177,177 |
| Amortization Of Intangibles | - | $1,294,266 | $1,282,394 | $177,177 |
| Net Income From Continuing Operations | - | $-9,430,513 | $-5,757,286 | $-2,343,563 |
| Change In Accrued Expense | - | - | - | $19,288 |
| Change In Interest Payable | - | - | - | $19,288 |
| Change In Payable | - | - | - | $124,876 |
| Change In Account Payable | - | - | - | $124,876 |
| Gain Loss On Investment Securities | - | - | - | $262,701 |
Fetched: 2026-02-02